MEF2D-BCL9 Fusion Gene Is Associated With High-Risk Acute B-Cell Precursor Lymphoblastic Leukemia in Adolescents [BIOLOGY OF NEOPLASIA]

Conclusion
A novel MEF2D-BCL9 fusion we identified characterizes a novel subset of pediatric ALL, predicts poor prognosis, and may be a candidate for novel molecular targeting.

Source: Journal of Clinical Oncology - September 20, 2016 Category: Cancer & Oncology Authors: Suzuki, Okuno, Kawashima, Muramatsu, Okuno, Wang, Kataoka, Sekiya, Hamada, Murakami, Kojima, Narita, Narita, Sakaguchi, Sakaguchi, Yoshida, Nishio, Hama, Takahashi, Kudo, Kato, Kojima Tags: Translational Oncology, Acute Lymphoblastic Leukemia BIOLOGY OF NEOPLASIA Source Type: research